| Autor: |
Lindblom, Bertil, Nordmann, Jean-Philippe, Sellem, Eric, Chen, Enping, Gold, R., Polland, Werner, Williamson, W., Buchholz, Patricia, Walt, John G., Groleau, Danielle, Curry, Alistair, Evans, Stacy J. |
| Zdroj: |
Acta Ophthalmologica Scandinavica; February 2006, Vol. 84 Issue: 1 p74-83, 10p |
| Abstrakt: |
To assess resource utilization and costs associated with glaucoma management in France and Sweden.A total of 267 patient records (121 in France, 146 in Sweden) with diagnoses of primary open-angle glaucoma (POAG) and ocular hypertension (OH), treated medically, were reviewed for a 2-year period (beginning during 1997−99) for relevant clinical and resource utilization data. Economic data were applied to estimate treatment costs.The annual cost of treating glaucoma was estimated at SEK5305 (€531)/patient in Sweden and €390/patient in France. In both countries, medication costs comprised about half of the total costs. Surgical procedures and hospitalizations represented greater proportions of total cost in France (7.0% and 9.6%, respectively) than in Sweden (3.7% and 0.6%, respectively).Medication costs represent a high proportion of total treatment costs. These findings highlight the relative importance of medical therapy and of assessing the cost-effectiveness of medications in glaucoma. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
